SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending on news of its central role in the UK's Maritime Nuclear Consortium, aiming to pioneer nuclear-powered shipping solutions with its SMR technology. This strategic move, alongside robust performance in civil aerospace and defense contracts, is generating strong community optimism and driving positive analyst sentiment.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst widespread discussions surrounding its namesake's recent assertive statements concerning Greenland and potential tariffs on European nations. The community is deeply divided, debating the geopolitical ramifications and potential market impacts, with many expressing frustration over the pervasive political commentary overshadowing fundamental stock analysis.

ARPA Network (ARPA) is a decentralized secure computation network built to improve the fairness, security, and privacy of blockchains. ARPA threshold BLS signature network serves as the infrastructure of verifiable Random Number Generator (RNG), secure wallet, cross-chain bridge, and decentralized custody across multiple blockchains.   ARPA was previously known as ARPA Chain, a privacy-preserving Multi-party Computation (MPC) network founded in 2018. ARPA Mainnet has completed over 224,000 computation tasks in the past years. Our experience in MPC and other cryptography laid the foundation for our innovative threshold BLS signature schemes (TSS-BLS) system design and led us to today’s ARPA Network.   Randcast, a verifiable Random Number Generator (RNG), is the first application that leverages ARPA as infrastructure. Randcast offers a cryptographically generated random source with superior security and low cost compared to other solutions. Metaverse, game, lottery, NFT minting and whitelisting, key generation, and blockchain validator task distribution can benefit from Randcast’s tamper-proof randomness.

ARPA Chain

ARPA is trending with the community buzzing about "great AI news" and recent updates driving significant volume spikes. Many believe this, coupled with its relatively low market cap and real utility, positions it as a "sleeping giant" poised for substantial growth during the anticipated altcoin season. Investors are actively accumulating, anticipating a major price breakout.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is trending due to its rapid early-stage growth, which has seen its market capitalization and holder count increase significantly. Community sentiment is mixed, with many expressing optimism about its continued upward trajectory, while a substantial portion of the discussion focuses on reports of price discrepancies and availability issues on certain platforms like Coinbase, sparking debate around its legitimacy.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as an anticipated Arctic blast and polar vortex are expected to bring extreme cold across much of the U.S., driving up heating demand. The community is actively debating the potential for a massive short squeeze and significant price surge, while others caution about the instrument's historical volatility.

V2X, Inc. provides solutions and support to defense clients globally. It delivers integrated solutions across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. The company was founded in February 2014 and is headquartered in Reston, VA.

V2X Inc

V2X Inc. is trending due to a series of significant new defense contract wins, including its operational role at the strategically important Pituffik Space Force base and involvement in the Golden Dome project, alongside the deployment of its advanced Tempest counter-UAS system. The community is buzzing with optimism, highlighting V2X's expanding market opportunity and appreciating its position as an undervalued defense prime contractor experiencing robust contract momentum as a major shareholder's overhang lessens.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge Technologies is currently trending due to a wave of positive analyst upgrades and news surrounding its collaboration in the high-growth AI data center market. This has ignited strong bullish sentiment, with many anticipating significant future gains as the company executes its turnaround strategy. However, a highly vocal bearish contingent remains, highlighting past volatility and challenging the sustainability of the rally amidst broader sector concerns.

Monero

Monero (XMR) is experiencing significant upward momentum, as community discussion emphasizes its uncompromised, default privacy features amidst a landscape of increasing regulatory scrutiny on digital asset anonymity. Many are highlighting XMR's role as the "king of privacy," asserting its fundamental utility and superiority over other privacy-focused tokens due to its inherent untraceable transactions.

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Pacira BioSciences Inc

Pacira BioSciences is trending significantly upward following a favorable patent litigation settlement for its flagship product, EXPAREL, effectively delaying substantial generic competition into the next decade. This resolution is instilling renewed investor confidence and positive analyst sentiment, as it addresses a major overhang for the non-opioid pain management company.

Alchemy Pay

Alchemy Pay is actively trending as the community eagerly discusses its upcoming Level 1 upgrade and testnet, alongside the strategic development of Alchemy Chain as a stablecoin-focused L2. Bullish sentiment is fueled by numerous new fiat on-ramp partnerships and expansion of U.S. Money Transmitter Licenses, reinforcing its position as a key provider of compliant, enterprise-grade crypto-fiat payment solutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 1,800 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 1,800 shares of the stock in a transaction dated Tuesday, January 13th. The stock was purchased at an average...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 2,900 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 2,900 shares of the company's stock in a transaction dated Monday, January 12th. The shares were acquired at an...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases 2,900 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 2,900 shares of the business's stock in a transaction that occurred on Monday, January 12th. The shares were...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Buys $91,848.00 in Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 4,300 shares of Greenwich LifeSciences stock in a transaction that occurred on Wednesday, December 31st. The...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 4,300 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 4,300 shares of the business's stock in a transaction on Wednesday, December 31st. The stock was acquired at an...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases $63,017.00 in Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 2,900 shares of Greenwich LifeSciences stock in a transaction that occurred on Tuesday, December 30th. The...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Buys 2,900 Shares

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 2,900 shares of the company's stock in a transaction on Tuesday, December 30th. The shares were acquired at an...

FY2025 Earnings Estimate for GLSI Issued By HC Wainwright

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Equities researchers at HC Wainwright issued their FY2025 earnings estimates for shares of Greenwich LifeSciences in a report issued on...

What's Going On With Greenwich LifeSciences Stock Monday?

Greenwich LifeSciences shares are trading higher Monday after the company announced it extended its lock-up period to Sept. 30, 2026.read more...

<ul class="summary-bullets"><li>During this period, insiders will be restricted from selling their shares unless the board decides otherwise.</li><li>The lock-up helps align insiders with long-term shareholders while supporting the Phase III FLAMINGO-01 study of GLSI-100, CEO Snehal Patel said.</li><li>GLSI shares have been on a rally since the company announced progress in the FLAMINGO-01 trial on December 15, gaining more than 130%.</li></ul>Shares of Greenwich LifeSciences Inc. (GLSI) jumped 25% on Monday, to their highest since February 2022, after the company’s Board extended the lock-up period on shares held by directors, officers, and pre-IPO investors&nbsp;by six months, through Sept. 30, 2026 – roughly six years after the company’s initial public offering (IPO).During this period, insiders will be restricted from selling their shares unless the board decides otherwise. Any sales after that date would still be limited under a structured “leak-out” plan.Chief Executive Officer Snehal Patel said the longer lock-up helps align insiders with long-term shareholders while supporting the Phase III FLAMINGO-01 study of GLSI-100, an immunotherapy to prevent breast cancer recurrence.<a href="https://stocktwits.com/symbol/GLSI">GLSI shares</a> have been on a rally since the company announced progress in the FLAMINGO-01 trial on December 15, gaining more than 130%.&nbsp; The stock is on track to post its biggest monthly gain in five years.<h2 class="st-heading-2">FLAMINGO-01 Trial Progress</h2>FLAMINGO-01 is a global Phase III study testing GLSI-100 in HER2-positive breast cancer patients following standard treatment. More than 1,000 patients have been screened, with enrollment continuing across U.S. and European sites, the company said. Around 140 sites are actively enrolling patients, with plans to expand further in 2026.Preliminary data from the open-label non-HLA-A*02 arm, involving 250 treated patients, showed around 80% reduction in recurrence rates following the primary immunization series, which consists of six injections over six months. These early results appear consistent with findings from the company’s Phase IIb trial, though Greenwich cautioned that the data remains preliminary and subject to further review.In its earlier Phase IIb trial, GLSI-100 demonstrated an 80% or greater reduction in metastatic breast cancer recurrences over five years in treated patients, with a strong immune response and a favorable safety profile. These results underpin the design and expectations of the ongoing Phase III study, the company added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained in the ‘extremely bullish’ territory over the past 24 hours, amid ‘extremely high’ message volumes. GLSI was among the top trending tickers on the platform at the time of writing.<img src="https://news.stocktwits-cdn.com/GLSI_png_c5b2b8ee32.webp" alt="GLSI.png">One user believes that, given the large volume, a ‘big player’ could be buying in.<stembedurl>https://stocktwits.com/Whitevalkyrie01/message/640311249</stembedurl>Year-to-date, GLSI has gained more than 120%.Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/copper-sees-strong-rally-this-year-but-consolidation-in-2026/cL75wm5RExf">Copper Saw A Massive Rally This Year – Goldman Sachs Sees Consolidation In 2026</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did GLSI Stock Surge 25% Today?

The company’s Board extended the lock-up on shares held by directors, officers, and pre-IPO investors through Sept. 30, 2026.

Equity

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

GLSI
Greenwich LifeSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLSI News

GLSIGreenwich LifeSciences Inc